P

Inventor

BROGGINI DIEGO FERNANDO DOMENICO

CH9 patents
⚠️ This page may combine multiple inventors who share the name “BROGGINI DIEGO FERNANDO DOMENICO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ASTEX THERAPEUTICS LTD

4 patents
US10898482B2Jan 26, 2021

Pharmaceutical compositions comprising N-(3,5-dimethoxyphenyl)-N'-1 methylethyl)-N-[3-(1-methyl-1H-pyrazol-4-yl)quinoxalin-6-yl]ethane-1,2-diamine

ASTEX THERAPEUTICS LTD7 citations81
US10421747B2Sep 24, 2019

Quinoxaline derivatives useful as FGFR kinase modulators

ASTEX THERAPEUTICS LTD6 citations78
US9902714B2Feb 27, 2018

Quinoxaline derivatives useful as FGFR kinase modulators

ASTEX THERAPEUTICS LTD15 citations78
US11684620B2Jun 27, 2023

Pharmaceutical compositions comprising N-(3,5-dimethoxyphenyl)-N′-(1-methylethyl)-N-[3-(1-methyl-1H-pyrazol-4-yl)quinoxalin-6-yl]ethane-1,2-diamine

ASTEX THERAPEUTICS LTD0 citations59

JANSSEN PHARMACEUTICA NV

4 patents
US10323002B2Jun 18, 2019

Process for the preparation of histamine H3 receptor modulators

JANSSEN PHARMACEUTICA NV0 citations49
US9809547B2Nov 7, 2017

Process for the preparation of histamine H3 receptor modulators

JANSSEN PHARMACEUTICA NV0 citations49
US11542247B2Jan 3, 2023

Bi-heteroaryl substitute 1,4-benzodiazepines and uses thereof for the treatment of cancer

JANSSEN PHARMACEUTICA NV0 citations47
US11155555B2Oct 26, 2021

Compounds

JANSSEN PHARMACEUTICA NV0 citations45

BRISTOL MYERS SQUIBB CO

1 patent
US12378246B2Aug 5, 2025

Synthetic options towards the manufacture of (6R,10S)-10-{4-[5-chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-6-oxo-1(6H)-pyrimidinyl} - 1-(difluoromethyl)-6-methyl-1,4,7,8,9,10-hexahydro-11,15-(metheno)pyrazolo[4,3-b][1,7]diazacyclotetradecin-5(6H)-one

BRISTOL MYERS SQUIBB CO0 citations42